Crossmark Global Holdings, Inc. - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 153 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Crossmark Global Holdings, Inc. ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$311,0000.0%27,7700.0%0.01%0.0%
Q3 2016$311,00027,7700.01%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,663,281$16,300,0009.19%
Nantahala Capital Management 1,891,328$18,535,0002.06%
Nine Chapters Capital Management LLC 40,700$399,0000.54%
MENTA CAPITAL LLC 396,336$3,884,0000.38%
Sapphire Star Partners LP 30,439$298,0000.34%
TFS CAPITAL LLC 95,432$935,0000.30%
Ativo Capital Management LLC 123,428$1,210,0000.30%
GLG Partners LP 363,188$3,559,0000.17%
GSA CAPITAL PARTNERS LLP 240,013$2,352,0000.13%
Bowling Portfolio Management LLC 68,473$671,0000.11%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders